Let me rephrase: In the US Stribild market is #1 in the first-line setting and #1 in new switches in the second-line setting. It's not yet #1 in total sales because there are many patients who are currently stable on other regimens.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.